{
    "nctId": "NCT06061666",
    "briefTitle": "Treatment of Insomnia in Patients With Breast Cancer",
    "officialTitle": "TILIA for inSomnia During HOrmonal Therapy in Breast Cancer Survivors",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Insomnia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Tilia tomentosa glyceric macerate effectiveness against insomnia of brest cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients capable of giving informed consent\n* Patients undergoing surgery to remove breast tumors and undergoing hormone therapy (any stage)\n* Patients who present a score \\> 5 on the \"Pittsburgh Sleep Quality Index (PSQI)\" questionnaire on sleep quality\n* Patients aged between 18 and 65 years\n\nExclusion Criteria:\n\n* Children under 18 and people over 65\n* Pregnant or breastfeeding women\n* Patients with breast cancer undergoing chemotherapy and/or radiotherapy\n* Serious concomitant diseases (other neoplasms, liver failure, renal failure, and hyperthyroidism, ulcerative colitis, Crohn's disease)\n* Patients being treated with antibiotics in the month preceding screening\n* Patients being treated with drugs that alter the sleep-wake rhythm (anxiolytics, hypnotics, non-benzodiazepine hypnotics, major sedatives, antipsychotics, antiepileptics, opiates)\n* Known hypersensitivity to Tilia tomentosa",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}